Expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in oral squamous cell carcinomas

被引：0
|
作者：
Radhakrishnan, R. [1 ]
Shrestha, B. [1 ]
Bajracharya, D. [1 ]
机构：
[1] Manipal Univ, Manipal Coll Dent Sci, Manipal, India
来源：
ORAL ONCOLOGY | 2011年 / 47卷
关键词：
D O I：
10.1016/j.oraloncology.2011.06.274
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [1] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    [J]. LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [2] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [3] Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma
    Yoshizaki, T
    Maruyama, Y
    Sato, H
    Furukawa, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 95 (01) : 44 - 50
  • [4] Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium
    Chung, HW
    Lee, JY
    Moon, HS
    Hur, SE
    Park, MH
    Wen, Y
    Polan, ML
    [J]. FERTILITY AND STERILITY, 2002, 78 (04) : 787 - 795
  • [5] Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
    Kanayama, H
    Yokota, K
    Kurokawa, Y
    Murakami, Y
    Nishitani, M
    Kagawa, S
    [J]. CANCER, 1998, 82 (07) : 1359 - 1366
  • [6] Effects of valsartan on matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in atrial fibrillation patients
    裴晓阳
    潘莹
    颜雯
    胡雪松
    [J]. South China Journal of Cardiology, 2010, 11 (01) : 15 - 19
  • [7] Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis
    Kang, Shan
    Zhao, Xiwa
    Xing, Huimin
    Wang, Na
    Zhou, Rongmiao
    Chen, Shucheng
    Li, Wansheng
    Zhao, Jian
    Duan, Yanan
    Sun, Donglan
    Li, Yan
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (03) : 226 - 231
  • [8] Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma
    Xu, KX
    Hou, SK
    Du, ZJ
    [J]. CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 743 - 745
  • [9] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis
    Li, Bing-Hui
    Zhao, Peng
    Liu, Shi-Zheng
    Yu, Yue-Ming
    Han, Mei
    Wen, Jin-Kun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (20) : 3046 - 3050
  • [10] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 gene polymorphisms in multiple sclerosis
    Benesova, Y.
    Beranek, M.
    Hladikova, M.
    Vacha, J.
    Kadanka, Z.
    Vasku, A.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 : 68 - 68
12345